Literature DB >> 18479159

Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.

Takatoshi Nakagawa1, Eiji Miyoshi, Takayuki Yakushijin, Naoki Hiramatsu, Takumi Igura, Norio Hayashi, Naoyuki Taniguchi, Akihiro Kondo.   

Abstract

The N-glycan structures of the Lens culinaris agglutinin (LCA)-reactive fraction of alpha-fetoprotein (AFP-L3), a tumor marker of hepatocellular carcinomas (HCC), were analyzed in relationship to glycosyltransferases and LCA-affinity electrophoresis. Using HPLC and MALDI-TOF MS, we determined the N-glycan structures of AFP from HCC cell lines, and demonstrated they were affected by N-acetylglucosaminyltransferase III and fucosyltransferase VIII, but not by N-acetylglucosaminyltransferase V. Moreover, we identified the N-glycan structures of AFP in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479159     DOI: 10.1021/pr700841q

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  26 in total

1.  Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.

Authors:  Patrick R Romano; Andrew Mackay; Minh Vong; Johann DeSa; Anne Lamontagne; Mary Ann Comunale; Julie Hafner; Timothy Block; Ryszard Lec; Anand Mehta
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

Review 2.  Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

Authors:  Jianhui Zhu; Elisa Warner; Neehar D Parikh; David M Lubman
Journal:  Mass Spectrom Rev       Date:  2018-11-25       Impact factor: 10.946

3.  A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.

Authors:  Yuka Kobayashi; Hiroaki Tateno; Hideo Dohra; Kenta Moriwaki; Eiji Miyoshi; Jun Hirabayashi; Hirokazu Kawagishi
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

4.  Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.

Authors:  Karen L Abbott; Jae-Min Lim; Lance Wells; Benedict B Benigno; John F McDonald; Michael Pierce
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984

5.  From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises.

Authors:  Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

6.  Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.

Authors:  Haidi Yin; Zhijing Tan; Jing Wu; Jianhui Zhu; Kerby A Shedden; Jorge Marrero; David M Lubman
Journal:  J Proteome Res       Date:  2015-10-02       Impact factor: 4.466

7.  ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.

Authors:  Yiwei Zhang; Jianhui Zhu; Haidi Yin; Jorge Marrero; Xin-Xiang Zhang; David M Lubman
Journal:  J Proteome Res       Date:  2015-11-03       Impact factor: 4.466

8.  Chemically-blocked antibody microarray for multiplexed high-throughput profiling of specific protein glycosylation in complex samples.

Authors:  Chen Lu; Joshua L Wonsidler; Jianwei Li; Yanming Du; Timothy Block; Brian Haab; Songming Chen
Journal:  J Vis Exp       Date:  2012-05-04       Impact factor: 1.355

9.  Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.

Authors:  Wan-Ju Xu; Bao-Li Guo; Yu-Gang Han; Lei Shi; Wan-Shan Ma
Journal:  Tumour Biol       Date:  2014-09-12

10.  Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.

Authors:  López-Cortés Rubén; Muinelo-Romay Laura; Fernández-Briera Almudena; Gil Martín Emilio
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.